Company Overview

Development Stage

About the Company

[Summary] 专注生物和创新药领域,提升国民医疗和健康水平

浙江博锐生物制药股份有限公司(简称“博锐生物”)是一家具备全方位研发、生产及商业化能力的创新型生物制药企业。公司聚焦于免疫领域,自身免疫以协同科室全覆盖为布局主线,肿瘤免疫以细胞类型覆盖为靶点布局主线,可为患者提供全面且多样性的产品组合及解决方案。
公司建有生物药规模化产能和卓越的质量管理体系,从候选药物筛选到临床开发的全周期研发能力及覆盖全国的商业化平台。公司具有20+主要在研产品,其中10+已进入临床和7个已商业化上市。目前公司在全球拥有1800+员工,分布在中国台州、杭州、上海和美国圣地亚哥,致力于成为品质卓越、广受信赖的生物制药公司。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

博锐生物 Financing History (1 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 15亿人民币
  • Investor: 台州国有资本运营集团,富阳...

博锐生物 Recruitment Overview / Current Status (467 open positions)

Manage
Note: How fast is hiring at 浙江博锐生物制药股份有限公司 growing? 博锐生物2026: 879 openings, 2025: 39 openings, 2023: 133 openings, 2022: 110 openings, 2021: 79 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

博锐生物 Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at 浙江博锐生物制药股份有限公司 growing? 博锐生物Master's recruitment over the years: 2026: 50 openings, 2023: 28 openings, 2022: 31 openings, 2021: 2 openings.

博锐生物 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
博锐生物 Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 浙江博锐生物制药股份有限公司 growing? 博锐生物Doctorate recruitment over the years: 2026: 4 openings, 2023: 2 openings, 2022: 6 openings.

博锐生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 浙江博锐生物制药股份有限公司? Based on an analysis of 博锐生物's job postings over the past year, "医疗卫生/美容保健类" demand: 32.3%, "计算机/网络/技术类": 30.4%, "生物/制药/化工/环保类": 7.9%, "其他(研发和技术类)": 3.1%, "机械/仪器仪表类": 1.6%, "电子/电器/通信技术类": 1%. For reference only.

博锐生物 — What Are the Salaries Like? (839 records)

Manage
salary range: 3K - 50K, 69.2% of roles pay ¥10-30K
Note: salary statistics are based on 839 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 浙江博锐生物制药股份有限公司?博锐生物69.2% of positions earn 10-30K, Fresh graduate salary: ¥5.7K。Taizhou salary ranking top 10,销售类 average salary ¥16.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 博锐生物

(More)
Are salaries high at 浙江博锐生物制药股份有限公司? We provide: 信息,医药代表,销售,地区经理,qa,ka,高级经理,sa,管工,验证工程师,大区经理,产品经理,市场,运营,大客户,临床,商务主管,实习生,qc,准入经理. Click to view detailed salary analysis by job.

博锐生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

博锐生物 Related Industry Tags

Job Category

  • 销售类
    57.4% of total 57.4%
  • 医疗卫生/美容保健类
    33.3% of total 33.3%
  • 计算机/网络/技术类
    31.3% of total 31.3%
  • 经营管理类
    16% of total 16%

Education

  • 本科
    52.4% of total 52.4%
  • 大专
    34.3% of total 34.3%
  • 不限
    7.1% of total 7.1%
  • 硕士
    5.8% of total 5.8%

Experience

  • 不限
    32.1% of total 32.1%
  • 1-3年
    24.8% of total 24.8%
  • 3-5年
    24% of total 24%
  • 5-10年
    18.5% of total 18.5%
View Detailed Analysis

What does 浙江博锐生物制药股份有限公司 require? Who is 博锐生物 hiring? 博锐生物 recruitment: 销售类占比最多占57.4%,其次是医疗卫生/美容保健类占33.3%. What education can get in at 博锐生物? 本科占比最多占52.4%,其次是大专占34.3%. High education required at 博锐生物? 硕士占5.8%,博士占0.4%. Work experience required at 博锐生物? 不限占比最多占32.1%,其次是1-3年占24.8%. Where are the job locations at 博锐生物? 上海占比最多占27.1%,其次是杭州占15.9%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 67,204.6703万(元)
Legal Representative: 肖遂宁
Date Established:
Credit Code: 91331002MA2DTHGU4M
Registered Address: 浙江省台州市椒江区疏港大道1号

Partners & Suppliers

博锐生物与石药集团就某抗体新药签署战略合作协议,石药集团获得大中华区开发和商业化权益。 Source
合作客户 商业化合作
博锐生物委托药明生物为其提供抗体药物的生产服务。 Source
供应商 委托生产
博锐生物与正大天晴就阿达木单抗生物类似药签署合作开发协议,正大天晴负责在中国大陆的市场推广和销售。 Source
合作客户 商业化合作
博锐生物就阿达木单抗生物类似药(博优诺)与华东医药签署商业化合作协议,华东医药获得中国大陆独家商业化权益。 Source
合作客户 商业化合作
博锐生物与浙江大学药学院共建联合实验室,开展抗体药物研发合作。 Source
供应商 高校/研究院合作

People who follow 博锐生物 also follow

博锐生物 Competitors (Similar Companies)

“Embracing all with generosity, pursuing the right path with perseveran”
“A provincial high-tech enterprise specializing in the development, pro”
“To develop high-quality biologics that are accessible and affordable f”
制药/药业 医药 儿童药 酮康唑
“An innovative biopharmaceutical enterprise focusing on antibody drugs”
“Helping partners successfully develop new drugs, reducing R&D costs an”
医药 生物医药 单克隆抗体药物 高通量筛选
“A pharmaceutical company specializing in the marketing, promotion, and”
“Research, development, and production of anti-tumor and surgical medic”
“Helping patients access more effective medicines sooner”
“A pharmaceutical enterprise integrating pharmaceutical preparations an”
“Refine, Detail, Strengthen”
“Steroid APIs and preparations. Produce first-class products, committed”
睫毛膏 眼影粉 口红 眼线液
“氟喹诺酮原料药主要生产基地”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates